Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SunWay Biotech CoROCO:1271 -4.39%90 EV-to-FCF is 35.78 as of Jul. 15, 2026, which is 4% above its 10-year median of 34.35. GuruFocus rates ROCO:1271 with a GF Score™ of 90/100 and a GF Value™ of NT$71.11 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 1,189 Consumer Packaged Goods companies, SunWay Biotech Co ranks worse than 77.29% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, SunWay Biotech Co's Enterprise Value is NT$4,253.4 Mil.
SunWay Biotech Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was NT$118.9 Mil. Therefore, SunWay Biotech Co's EV-to-FCF for today is 35.78.
The historical rank and industry rank for SunWay Biotech Co's EV-to-FCF or its related term are showing as below:
ROCO:1271'
s EV-to-FCF Range Over the Past 10 Years
Min: 7.63 Med: 34.35 Max: 410.92
Current: 36.95
During the past 7 years, the highest EV-to-FCF of SunWay Biotech Co was 410.92. The lowest was 7.63. And the median was 34.35.
ROCO:1271's EV-to-FCF is ranked worse than 77.29% of 1189
companies
in the Consumer Packaged Goods industry
Industry Median: 15.86
vs ROCO:1271: 36.95
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
SunWay Biotech Co (ROCO:1271) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
SunWay Biotech Co's PE Ratio (TTM) for today is calculated as:
SunWay Biotech Co's share price for today is NT$61.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. SunWay Biotech Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was NT$1.680.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
SunWay Biotech Co EV-to-FCF Related Terms
SunWay Biotech Co EV-to-FCF Historical Data
* Premium members only.
The historical data trend for SunWay Biotech Co's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, SunWay Biotech Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SunWay Biotech Co EV-to-FCF vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, SunWay Biotech Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where SunWay Biotech Co's EV-to-FCF falls into.
SunWay Biotech Co's current Enterprise Value is NT$4,253.4 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. SunWay Biotech Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was NT$118.9 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SunWay Biotech Co (ROCO:1271) has a EV-to-FCF of 35.78 as of Jul. 15, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on SunWay Biotech Co and its competitors. This is near median its historical median of 34.35. Over the past decade, SunWay Biotech Co's EV-to-FCF has ranged from 7.63 to 410.92. According to the industry distribution chart, SunWay Biotech Co ranks #919 out of 1189 companies in the Consumer Packaged Goods industry, placing it in the top 77.3%.
Is SunWay Biotech Co's EV-to-FCF too high?
SunWay Biotech Co's current EV-to-FCF of 35.78 is near median its 10-year median of 34.35. Over the past 10 years, this metric has ranged from a low of 7.63 to a high of 410.92. The Consumer Packaged Goods industry median EV-to-FCF is 15.86. SunWay Biotech Co's value of 35.78 is 125.6% above this industry median. Based on the distribution chart, SunWay Biotech Co ranks #919 out of 1189 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, SunWay Biotech Co has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does SunWay Biotech Co's EV-to-FCF compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, SunWay Biotech Co ranks #919 out of 1189 companies for EV-to-FCF. This places SunWay Biotech Co in the lower half of its industry. The industry median EV-to-FCF is 15.86. SunWay Biotech Co's value of 35.78 is 125.6% above this benchmark. Historically, SunWay Biotech Co's own EV-to-FCF has ranged from 7.63 to 410.92 over the past decade. While the company's 10-year median is 34.35 vs. the industry median of 15.86, SunWay Biotech Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Consumer Packaged Goods company?
The median EV-to-FCF among Consumer Packaged Goods companies is 15.86, based on 1,189 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SunWay Biotech Co's current EV-to-FCF of 35.78 is 125.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on SunWay Biotech Co and its competitors. For the Consumer Packaged Goods industry, the median EV-to-FCF is 15.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SunWay Biotech Co's current EV-to-FCF is 35.78, which is near median its own 10-year median of 34.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SunWay Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, SunWay Biotech Co (ROCO:1271) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$71.11, compared to a current price of NT$61.00 — trading 14.2% below its estimated fair value. The current EV-to-FCF is 35.78, which is near median its 10-year median of 34.35 and 125.6% above the Consumer Packaged Goods industry median of 15.86. SunWay Biotech Co's overall GF Score™ is 90/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For SunWay Biotech Co (ROCO:1271), the current EV-to-FCF is 35.78 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SunWay Biotech Co (ROCO:1271) Overvalued in 2026?
Based on GuruFocus' analysis, SunWay Biotech Co stock appears to be undervalued.
The current stock price of NT$61.00 is trading 14.2% below its estimated GF Value™ of NT$71.11.
GuruFocus considers SunWay Biotech Co to be Modestly Undervalued.
Key valuation signals for ROCO:1271:
EV-to-FCF: 35.78 (near median its 10-year median of 34.35)
GF Value™: NT$71.11 vs. price of NT$61.00 (14.2% below fair value)
Industry Position: 125.6% above the Consumer Packaged Goods median (#919 of 1189)
No single metric tells the full story. See the ROCO:1271 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SunWay Biotech Co Ltd is engaged in the research, design and manufacturing of Monascus purpureus NTU 568, Lactobacillus paracasei subsp, paracasei NTU 101, and the related products.
90GF Score
Get the complete analysis for ROCO:1271
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:1271 has been successfully added to your 
